Gilead rises after pricing its coronavirus-fighting drug remdesivir (GILD)

**

· *Gilead Sciences on Monday disclosed its pricing for remdesivir, its coronavirus-fighting drug. *
· *Shares of the company jumped as much as 4% in premarket trading. *
· *The company will charge the US government and developed countries $390 per vial of remdesivir, or $2,340 for a five-day course using six vials of...